Omnibus WAIVEROmnibus Waiver • July 20th, 2017 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 20th, 2017 Company Industry JurisdictionThis OMNIBUS WAIVER (this “Waiver”) is made and entered into as of July 15, 2017 by ROS acquisition offshore lp (“ROS”), ORBIMED ROYALTY OPPORTUNITIES II, LP (“Royalty Opportunities”), BRUCE FUND, INC. (“Bruce Fund”), PARK WEST PARTNERS INTERNATIONAL, LIMITED (“PWPI”), PARK WEST INVESTORS MASTER FUND, LIMITED (“PWIMF”) and TELEMETRY SECURITIES, L.L.C. (“Telemetry” and, together with ROS, Royalty Opportunities, Bruce Fund, PWPI and PWIMF, collectively, the “Holders”).